These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8733007)

  • 21. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.
    Weber KT; Brilla CG
    Circulation; 1991 Jun; 83(6):1849-65. PubMed ID: 1828192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversal of cardiac fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the renin-angiotensin system.
    Brown L; Duce B; Miric G; Sernia C
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S143-8. PubMed ID: 9892155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aldosterone antagonists in hypertension and heart failure.
    Mantero F; Lucarelli G
    Ann Endocrinol (Paris); 2000 Feb; 61(1):52-60. PubMed ID: 10790593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Rho kinase and oxidative stress in cardiac fibrosis induced by aldosterone and salt in angiotensin type 1a receptor knockout mice.
    Kagiyama S; Matsumura K; Goto K; Otsubo T; Iida M
    Regul Pept; 2010 Feb; 160(1-3):133-9. PubMed ID: 19969025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: role of endothelin-1.
    Park JB; Schiffrin EL
    Am J Hypertens; 2002 Feb; 15(2 Pt 1):164-9. PubMed ID: 11863252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aldosterone-induced inflammation in the rat heart : role of oxidative stress.
    Sun Y; Zhang J; Lu L; Chen SS; Quinn MT; Weber KT
    Am J Pathol; 2002 Nov; 161(5):1773-81. PubMed ID: 12414524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic hyperaldosteronism in a transgenic mouse model fails to induce cardiac remodeling and fibrosis under a normal-salt diet.
    Wang Q; Clement S; Gabbiani G; Horisberger JD; Burnier M; Rossier BC; Hummler E
    Am J Physiol Renal Physiol; 2004 Jun; 286(6):F1178-84. PubMed ID: 14761862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
    Endemann DH; Touyz RM; Iglarz M; Savoia C; Schiffrin EL
    Hypertension; 2004 Jun; 43(6):1252-7. PubMed ID: 15117913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrophage mineralocorticoid receptor signaling plays a key role in aldosterone-independent cardiac fibrosis.
    Bienvenu LA; Morgan J; Rickard AJ; Tesch GH; Cranston GA; Fletcher EK; Delbridge LM; Young MJ
    Endocrinology; 2012 Jul; 153(7):3416-25. PubMed ID: 22653557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mineralocorticoid excess, dietary sodium, and myocardial fibrosis.
    Brilla CG; Weber KT
    J Lab Clin Med; 1992 Dec; 120(6):893-901. PubMed ID: 1453111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation and role of myocardial collagen matrix remodeling in hypertensive heart disease.
    Funck RC; Wilke A; Rupp H; Brilla CG
    Adv Exp Med Biol; 1997; 432():35-44. PubMed ID: 9433509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Celecoxib, but not rofecoxib or naproxen, attenuates cardiac hypertrophy and fibrosis induced in vitro by angiotensin and aldosterone.
    Wang BH; Bertucci MC; Ma JY; Adrahtas A; Cheung RY; Krum H
    Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):912-8. PubMed ID: 20497423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aldosterone-and-salt-induced cardiac fibrosis is independent from angiotensin II type 1a receptor signaling in mice.
    Kagiyama S; Matsumura K; Fukuhara M; Sakagami K; Fujii K; Iida M
    Hypertens Res; 2007 Oct; 30(10):979-89. PubMed ID: 18049031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early inflammatory responses in experimental cardiac hypertrophy and fibrosis: effects of 11 beta-hydroxysteroid dehydrogenase inactivation.
    Young MJ; Moussa L; Dilley R; Funder JW
    Endocrinology; 2003 Mar; 144(3):1121-5. PubMed ID: 12586788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mineralocorticoids, hypertension, and cardiac fibrosis.
    Young M; Fullerton M; Dilley R; Funder J
    J Clin Invest; 1994 Jun; 93(6):2578-83. PubMed ID: 8200995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biological determinants of aldosterone-induced cardiac fibrosis in rats.
    Robert V; Silvestre JS; Charlemagne D; Sabri A; Trouvé P; Wassef M; Swynghedauw B; Delcayre C
    Hypertension; 1995 Dec; 26(6 Pt 1):971-8. PubMed ID: 7490157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of the glucocorticoid receptor in mineralocorticoid/salt-mediated cardiac fibrosis.
    Rickard AJ; Funder JW; Fuller PJ; Young MJ
    Endocrinology; 2006 Dec; 147(12):5901-6. PubMed ID: 16990342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adrenal steroids and cardiac fibrosis.
    Young M
    Steroids; 1995 Jan; 60(1):133-6. PubMed ID: 7792798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion.
    Sun Y; Ramires FJ; Weber KT
    Cardiovasc Res; 1997 Jul; 35(1):138-47. PubMed ID: 9302358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Na/H exchange isoform 1 is involved in mineralocorticoid/salt-induced cardiac injury.
    Fujisawa G; Okada K; Muto S; Fujita N; Itabashi N; Kusano E; Ishibashi S
    Hypertension; 2003 Mar; 41(3):493-8. PubMed ID: 12623949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.